ArticleJournal of multidisciplinary healthcare2025
Effect of Cognitive Behavioral Therapy for Insomnia on Stellate Ganglion Block Treatment for Chronic Insomnia.
Article in Journal of multidisciplinary healthcare, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Superior autonomic regulation with ropivacaine over lidocaine in stellate ganglion block for chronic insomnia: a randomized controlled trial.BMC anesthesiology · 2026Trial
- Effect of high-frequency stellate ganglion block on sleep and affective symptoms in insomnia disorder: a prospective pilot study.BMC neurology · 2026Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic insomnia is a prevalent health concern. Treatment methods for chronic insomnia encompass medication therapy, psychotherapy, physical therapy, and sympathetic nerve regulation therapy. The synergistic effects of these various therapeutic approaches warrant further investigation. Objective: This study aims to evaluate the impact of cognitive behavioral therapy for insomnia (CBT-I) in conjunction with stellate ganglion block (SGB) treatment on patients suffering from chronic insomnia. Patients and Methods: Patients diagnosed with chronic insomnia who were admitted to the anesthesia outpatient department between January 2023 and September 2024 were selected for this study. They were divided into two groups: the SGB group (Group S) and the CBT-I combined with SGB group (Group CS). Group S received ultrasound-guided SGB using 0.375% ropivacaine at a volume of 4 mL alternately on both sides, administered twice weekly over a period of 6 weeks. Group CS underwent CBT-I concurrently with SGB following the same protocol as Group S for 6 weeks. The Insomnia Severity Index (ISI), Epworth Sleepiness Scale (ESS), and hypnotic medication were recorded before treatment as well as at 6 weeks and 12 weeks after treatment. Results: The ISI and ESS scores were significantly decreased than before treatment at 6 weeks after treatment in group S ( Conclusion: CBT-I substantially enhances the efficacy of stellate ganglion block treatment for chronic insomnia, reducing reliance on hypnotic medications; furthermore, sustains stable long-term outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.